<qa>  What is the goal of the study?The purpose of the study is to assess the objective response rate change in tumor size from baseline in patients with advanced or metastatic squamous cell nonsmall-cell lung cancer treated with Nivolumab BMS-936558 after failure of 2 prior systemic regimens 